Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Quanta, etc...

Perhaps our early bird dicounts are for end users paying a one time fee instead of ongoing royaties? Because are stated program is for ongoing royalties.

From TPL site: "The MMP Portfolio Licensing Program therefore focuses licensing requirements and royalty collection on the finished "system-level" product. A royalty-free MMP Portfolio license is also available to manufacturers of chips and other unfinished goods



Share
New Message
Please login to post a reply